Evaluation of adiponectin level in children and adolescents with diabetes type 1;Ocena stȩżenia adiponektyny u dzieci i młodzieży z cukrzyca̧ typu 1

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 14, Issue 2, 2008, Pages 77-81

  Peczyńska, Jadwiga ^a,b   Urban, Mirosława ^a   Głowińska, Barbara ^a   Florys, Bozena ^a  

^a Il Klinika Chorób Dzieci AM W Bia ymstoku

^b UM   (Poland)

Author keywords

Adiponectin; Children; Diabetes mellitus type 1

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; LIPID; CREATININE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; BODY MASS; CHILDHOOD DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; SCHOOL CHILD; BLOOD; CHILD; DIABETIC ANGIOPATHY; METABOLISM; SEX DIFFERENCE;

ADIPONECTIN; ADOLESCENT; ADULT; CHILD; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 84904850374     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pańkowska E., Szalecki M.: Adiponektyna - hormon tkanki tłuszczowej i jej zwia̧zek z zespołem metabolicznym i chorobami układu kra̧żenia. Endokrynol. Diabetol. Chor. Przemiany Materii Wieku Rozw., 2005, 11, 187-190.
2. Scherer P.E., Wiliams S., Fogliano M. i wsp.: A novel serum protein similar to C1g produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-26749.
3. Adamczak M., Rzepka E., Chudek J., Wiecek A.: Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin. Endocrinol. (Oxf.), 2005, 62, 114-118.
4. Chan D.C., Watts G.F., Ng T.W. i wsp.: Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin. Chem., 20055, 1,3, 578-585.
5. Zasadzińska G., Saryusz-Wolska M., Miłosz D., Loba J.: Adiponektyna - czy kolejna cytokina wydzielana przez tkankȩ tłuszczowa̧. Diabetol. Pol., 2004, 11, 208-213.
6. Fasshauer M., Klein J., Neumann S.: Hormonal regulation of adiponectin gene expression in 3T3- L1 adipocytes. Biochem. Biophys. Res. Commun., 2003, 21. 1045-1450.
7. Punthakee Z., Delvin E.E., O'Loughlin J. i wsp.: Adiponectin, adiposity, and insulin resistance in children and adolescents. J. Clin. Endocrinol. Metab., 2006, 91, 2119-2125.
8. Morales A., Wasserfall C., Brusko T. i wsp.: Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care, 2004, 27, 2010-2014.
9. Sabin M.A, Holly J.M., Shield J.P. i wsp.: Mature subcutaneous and visceral adipocyte concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score. J. Clin. Endocrinol. Metab., 2006, 91, 332-325.
10. Matyszko J., Matyszko J.S., Brzosko S. i wsp.: Adiponectin is related to CD146. a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneale dialyzed patients. J. Clin. Endocrinol. Metab., 2004, 89, 4620-4627.
11. Martos-Moreno G.A., Barrios V., Soriano-Guillen L., Argente J.: Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass in dex changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur. J. Endocrinol., 2006, 155, 757-761.
12. Zoccali C., Mallamaci F., Tripepi G.: Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int. 2003, 84, supl., S65-68.
13. Immagawa A., Funahashi T., Nakamura T. i wsp.: Elevated serum concentration of adipose-derived factor, adiponectin, inpatients with type 1 diabetes. Diabetes Care, 2002, 25, 1665-1670.
14. Celi F., Bini V., Papi F. i wsp.: Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet. Med., 2006, 23, 660-665.
15. Saraheimo M., Forsblom C., Fagerudd J. i wsp.: Serum adipomectin is increased In type 1 diabetic patients with nephropathy. Diabetes Care, 2005, 28, 1410-1414.
16. Schalkwijk C.G., Chaturvedi N., Schram M.T. i wsp. and EURODIAB Prospective Complications Study Group: Adiponectin is inversely associated with renal function in type 1 diabetic patients. J. Clin. Endocrinol. Metab., 2006, 91, 129-135.
17. Schulze M.B., Shai I., Rimm E.B. i wsp.: Adiponectin and future coronary hart disease events among men with type 2 diabetes. Diabetes, 2005, 54, 534-539.
18. Zoccali C., Tripepi G., Cambareri F. i wsp.: Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. Ren. Nutr., 2005, 15, 125-130.